Medicare Enrolled
Dr. Haris Mirza, MD
Infectious Disease · Ocala, FL
Practice pattern: Mixed Practice
— Diverse clinical practice across multiple procedure types
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating.
This page presents federal public records about Dr. Mirza from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Mirza?
Request a correction or review of any data shown here. Provider portal →
What this data tells you about Dr. Mirza
Dr. Haris Mirza is an infectious disease specialist in Ocala, FL, with 20 years of NPI registration. Based on federal Medicare data, Dr. Mirza performed 386,405 Medicare services in 2023. These records do not provide a deduplicated patient total.
Between the years covered by Open Payments, Dr. Mirza received a total of $9,562 from 52 pharmaceutical and/or device companies across 516 payment records. A record can group multiple payments. These transfers are publicly reported through CMS Open Payments. Disclosure alone does not establish their effect on care. A reliable breakdown by payment category is not available in this snapshot. Patients may wish to discuss these relationships with their provider.
The Data Coverage level for Dr. Mirza is Very High — reflecting how much public federal data is available about this provider. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.
✓ 20 years of NPI registration
▲ Top 2% volume in FL
$9,562 industry payments
Florida License Status
FL DOH · MQA1
Active license
None
Board action on record
0
Recent admin complaints
| Profession | License # | Status | Expires | Board Action |
|---|---|---|---|---|
| Medical Doctor | 88195 | Clear | January 31, 2027 | — |
Data from Florida Department of Health Medical Quality Assurance.
License records are public under Chapter 119, Florida Statutes.
Verify directly on FL DOH →
Medicare Practice Summary — 2023
Medicare Utilization ↗386,405
Medicare services
Top 2% in FL for infectious disease
Not available
Unique patients (not deduplicated)
$3
Avg. Medicare payment
Medicare patients only (65+ / disabled) · How to read this →
Top procedures by volume
Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.
| Procedure | Volume | Avg. paid | Avg. submitted |
|---|---|---|---|
| Daptomycin antibiotic injection | 352,097 | $0 | $0 |
| Injection, meropenem, 100 mg | 11,072 | $0 | $1 |
| Epifix, per square centimeter | 3,118 | $118 | $230 |
| Ceftriaxone antibiotic injection This code represents the administration of ceftriaxone sodium, an antibiotic medication. The charge is calculated for every 250 mg of the drug administered. |
2,801 | $0 | $1 |
| Normal saline infusion, 250 cc Administration of 250 cubic centimeters of normal saline solution into a vein. This procedure involves the intravenous delivery of a sterile saltwater fluid. |
2,673 | $1 | $1 |
| Injection, cefepime hydrochloride, 500 mg | 2,369 | $1 | $2 |
| Vancomycin injection, 500 mg A 500 mg dose of vancomycin antibiotic is administered via injection. |
2,338 | $2 | $4 |
| Office visit, established patient (30-39 min) A follow-up office visit for an existing patient lasting between 30 and 39 minutes. The visit involves medical evaluation and management of the patient's condition. |
2,004 | $95 | $189 |
| Intravenous drug injection A procedure involving the administration of a medication or substance directly into a vein. |
1,723 | $28 | $55 |
| Office visit, established patient (20-29 min) An office visit for an existing patient lasting between 20 and 29 minutes. The visit involves medical evaluation and management of the patient's condition. |
1,348 | $66 | $133 |
| Wound tissue removal, 20 sq cm or less This procedure involves the removal of tissue from a wound area measuring 20 square centimeters or less. |
1,149 | $75 | $147 |
| Intravenous infusion, 1 hour or less Administration of medication or fluid directly into a vein for therapeutic, preventive, or diagnostic purposes. The procedure lasts one hour or less. |
698 | $48 | $95 |
| Vein wound compression bandage application, lower leg, ankle, and foot Application of compression bandages to the lower leg, ankle, and foot to manage vein-related wounds. |
537 | $88 | $129 |
| Office visit, established patient, complex (40-54 min) An office or outpatient visit for an existing patient lasting between 40 and 54 minutes. This level of service is determined by the total time spent on the date of the encounter. |
373 | $134 | $266 |
| Intravenous injection of additional new drug or substance Administration of an additional new medication or substance directly into a vein. |
337 | $12 | $23 |
| Ertapenem sodium injection, 500 mg An injection of ertapenem sodium, an antibiotic medication, administered at a dose of 500 mg. |
254 | $10 | $48 |
| Strapping, unna boot | 246 | $45 | $94 |
| Office visit, established patient (10-19 min) An office visit for an existing patient lasting 10 to 19 minutes. The visit involves medical evaluation and management of the patient's condition. |
172 | $42 | $83 |
| Additional hour of intravenous infusion This code represents each additional hour of intravenous infusion beyond the initial hour for therapy, prevention, or diagnosis. |
156 | $16 | $38 |
| Skin substitute graft application, 25 sq cm or less Application of a skin substitute graft to a wound on the face, scalp, eyelids, mouth, neck, ears, around eyes, genitals, hands, feet, fingers, or toes. The wound area covered is 25.0 square centimeters or less. |
146 | $122 | $234 |
| Skin substitute graft application, 25 sq cm or less Application of a skin substitute graft to a wound on the trunk, arms, or legs covering 25 square centimeters or less. |
135 | $120 | $229 |
| New patient office visit (45-59 min) An initial office visit for a new patient lasting between 45 and 59 minutes. This code covers the total time spent by the physician or qualified healthcare professional on the date of the encounter. |
111 | $121 | $247 |
| Transitional care management services, moderate complexity Services provided to coordinate care during the transition from an inpatient or other facility setting back to the community. This includes follow-up and management of a health problem of at least moderate complexity. |
106 | $155 | $301 |
| New patient office visit, complex (60-74 min) | 75 | $165 | $328 |
| Wound tissue removal, each additional 20 sq cm This procedure involves the removal of tissue from a wound. It is billed for each additional 20 square centimeters of tissue removed beyond the initial amount. |
74 | $35 | $67 |
| Normal saline infusion, 500 ml Administration of sterile normal saline solution through an intravenous line. This procedure involves the infusion of a 500 ml unit of the solution. |
66 | $1 | $2 |
| Transitional care management, high complexity Coordination of care for a patient transitioning from a short-term hospital stay or other facility to home or another care setting. This service addresses a high-complexity medical problem. |
49 | $213 | $399 |
| Intravenous hydration infusion, 31-60 minutes Administration of fluids into a vein to maintain hydration. This procedure involves an infusion lasting between 31 and 60 minutes. |
47 | $25 | $47 |
| New patient office visit (30-44 min) An initial office visit for a new patient lasting between 30 and 44 minutes. This code is used when the total time spent on the date of the encounter falls within this range. |
40 | $82 | $166 |
| Office visit for established patient An office visit for an existing patient that may not require the healthcare professional to be present. |
40 | $16 | $34 |
| Drug injection, under skin or into muscle A procedure involving the administration of a medication or substance via injection into the subcutaneous tissue or muscle. |
30 | $11 | $21 |
| Hospital follow-up visit, high complexity Subsequent hospital inpatient or observation care for an existing patient involving high-level medical decision making, with at least 50 minutes total time on the date of the encounter. |
21 | $94 | $159 |
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. These counts do not measure clinical quality or years of experience.
0.9% high complexity
96.5% medium
2.5% routine
Industry Payment Transparency
Open Payments through 2024 ↗$9,562
Total received (2018-2024)
Avg $1,366/year across 7 years
Top 15% in FL for infectious disease
A higher payment rank reflects disclosed industry relationships (consulting, research, speaking) common among subspecialists — not wrongdoing.
52
Companies
516
Payment records
Payments are publicly reported; disclosure does not establish legality · Not evidence of wrongdoing · How to interpret →
Payment categories are unavailable while the source breakdown is being rebuilt. Company and year totals do not identify how much belongs to each category.
Payment trend by year
Annual totals from pharmaceutical and medical device companies.
2024
$1,870
2023
$1,491
2022
$1,590
2021
$1,024
2020
$949
2019
$1,522
2018
$1,117
Payments by company (2024)
Gilead Sciences, Inc.
$649
Averitas Pharma Inc.
$294
ViiV Healthcare Company
$251
Insmed, Inc.
$121
Theratechnologies Inc.
$108
Merck Sharp & Dohme LLC
$99
Smith+Nephew, Inc.
$61
ABBVIE INC.
$42
ConvaTec Inc.
$32
AIMMUNE THERAPEUTICS, INC.
$28
Grifols USA, LLC
$25
TerSera Therapeutics LLC
$23
Paratek Pharmaceuticals, Inc.
$22
Urgo Medical North America, LLC
$20
Salix Pharmaceuticals, a division of Bausch Health US, LLC
$18
Solventum Corporation
$15
MIMEDX Group, Inc.
$15
Ferring Pharmaceuticals Inc.
$14
Medtronic, Inc.
$14
CashFlow Solutions, LLC
$11
Advanced Oxygen Therapy Inc.
$8
Top 3 companies account for 63.8% of 2024 payments
All-time payments by company (2018-2024) ›
Gilead Sciences, Inc.
$2,289
ViiV Healthcare Company
$1,682
Merck Sharp & Dohme Corporation
$719
Janssen Biotech, Inc.
$626
Theratechnologies Inc.
$428
Merck Sharp & Dohme LLC
$426
Paratek Pharmaceuticals, Inc.
$396
Melinta Therapeutics, Inc.
$328
Averitas Pharma Inc.
$294
Insmed, Inc.
$253
Smith+Nephew, Inc.
$199
Nabriva Therapeutics, plc
$150
Allergan Inc.
$125
AIMMUNE THERAPEUTICS, INC.
$113
Janssen Products, LP
$100
Melinta Therapeutics, LLC
$100
PFIZER INC.
$98
Astellas Pharma US Inc
$97
Janssen Pharmaceuticals, Inc
$86
Bioventus LLC
$85
AbbVie Inc.
$75
TETRAPHASE PHARMACEUTICALS, INC.
$71
ConvaTec Inc.
$70
ABBVIE INC.
$62
Theravance Biopharma, Inc.
$56
Medtronic, Inc.
$50
KCI USA, Inc.
$49
MAYNE PHARMA INC.
$42
Shionogi Inc
$39
Shire North American Group Inc
$36
Takeda Pharmaceuticals U.S.A., Inc.
$32
Vyera Pharmaceuticals, LLC
$30
Acera Surgical, Inc.
$28
CashFlow Solutions, LLC
$26
Grifols USA, LLC
$25
TerSera Therapeutics LLC
$23
Genentech USA, Inc.
$22
ACELL, INC.
$20
Urgo Medical North America, LLC
$20
Integra LifeSciences Corporation
$19
Tactile Systems Technology Inc
$18
Hydrofera LLC
$18
Salix Pharmaceuticals, a division of Bausch Health US, LLC
$18
Solventum Corporation
$15
Napo Pharmaceuticals Inc
$15
MIMEDX Group, Inc.
$15
Ferring Pharmaceuticals Inc.
$14
Lifenet Health
$14
Milliken Healthcare Products, LLC
$14
Electromed, Inc.
$13
Medtronic Vascular, Inc.
$13
Advanced Oxygen Therapy Inc.
$8
Top 3 companies account for 49.0% of all-time payments
Associated products mentioned in payments ›
ACTIV.A.C. · ACTIVAC · AQUACEL AG+ · AVYCAZ · Abre · Allograft VMIS Delivery System · Arikayce · BILAYER WOUND MATRIX (BWM) · Baxdela · Biktarvy · CABENUVA · COLLAGENASE SANTYL · CRESEMBA · CUVITRU · Coflex TLC · DALVANCE · DIFICID · DORYX · DOVATO · Daraprim Tablet 25mg · EGRIFTA · ELIQUIS · Fetroja · Flexitouch Plus · HYDROFERA BLUE · HawkOne · INNOVAMATRIX AC · ISENTRESS · JULUCA · KerraMax Care · Kimyrsa · LYMPHA PRESS OPTIMAL PLUS(US) BT · Lympha Press Optimal Plus(US) BT · MAVYRET · Mytesi · NOXAFIL · NUZYRA · OCREVUS · OCTAGAM IMMUNE GLOBULIN (HUMAN) · Orbactiv · PANZYGA · PIFELTRO · PREZCOBIX · QUTENZA · Quzyttir · REBYOTA · RECARBRIO · REGRANEX · RENASYS GO v2 HOME · RENASYS TOUCH · RUKOBIA · Restrata Wound Matrix · SIVEXTRO · SMARTVEST · SNAP · SYMTUZA · Santyl · SonicOne Clinic · Symtuza · TRIUMEQ · TROGARZO · Topical Oxygen Chamber for extremities · VASHE WOUND SOLUTION 250 ML (8.5 FL OZ) FLIP TOP CAP · VENASEAL · VIBATIV · VOWST · Vabomere · XARELTO · XERAVA · XIFAXAN · Xembify · Xenleta · Xerava · ZERBAXA · ZINPLAVA
Should you be concerned? Industry payments are disclosed through CMS Open Payments. Disclosure alone does not establish their purpose, legality, or effect on care. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →
Geographic Context
Infectious diseases in nearby ZIP areas
8
County median income
$58,535
Nearest hospital to ZIP centroid (approximate)
MARION COMMUNTIY HOSPITAL
0.0 mi
0.0 mi
Data Sources
| Provider Registry | ✓ NPPES | NPPES snapshot; verify current record |
| Medicare Enrollment | ✓ PECOS | PECOS snapshot |
| Practice Data | ✓ Medicare Util. | Annual (CY lag) |
| Industry Payments | ✓ Open Payments | CY 2024 |
| Disciplinary History | — Not included | N/A |
This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This reflects how much public data is available about a provider. How we calculate this →
Summary
Dr. Mirza is a mixed practice specialist, with above-average Medicare volume (top 2% in FL), with 20 years of NPI registration.
This summary is auto-generated from federal data, describing data availability and patterns. Read our methodology →
Frequently Asked Questions
Is Dr. Mirza experienced with daptomycin antibiotic injection?
Based on Medicare claims data, Dr. Mirza performed 352,097 daptomycin antibiotic injection services. These records cover Medicare fee-for-service activity, including eligible younger beneficiaries; they do not measure total practice volume or clinical quality.
Does Dr. Mirza receive payments from pharmaceutical companies?
Yes. Dr. Mirza received a total of $9,562 from 52 companies across 516 payment records. A record can group multiple payments. These transfers are publicly disclosed through CMS Open Payments. Disclosure alone does not establish their legality or effect on care. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Mirza's costs compare to other infectious diseases in Ocala?
Dr. Mirza's average Medicare payment per service is $3. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Mirza) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating the presence of registry, enrollment, activity or payment records, not verified experience or clinical quality. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Source publication dates and the snapshots loaded on this site can differ. Rebuilding a page does not refresh its source records. Check the Medicare reporting year and the payment interval shown above; consult the linked official sources for newer releases and current registry details. See our data freshness policy →
Explore related providers
Same specialty & city
Infectious Diseases in Ocala
Browse infectious diseases in Ocala ranked by procedure volume and transparency data.
Highest volume
Top Infectious Diseases in FL
Infectious diseases ranked by total Medicare services performed statewide.
Industry payments
Pharma Payments to Infectious Diseases in FL
Which FL infectious diseases receive the most from drug and device companies.
By company
Gilead Sciences, Inc. Payments to Doctors
See all physicians who received payments from Gilead Sciences, Inc.
By company
ViiV Healthcare Company Payments to Doctors
See all physicians who received payments from ViiV Healthcare Company.
By company
Merck Sharp & Dohme Corporation Payments to Doctors
See all physicians who received payments from Merck Sharp & Dohme Corporation.
About this page
This page combines public CMS records with calculated summaries and explanatory procedure labels. These transformations are not verbatim federal records. Sources: NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.
This page is not medical advice, an endorsement, a recommendation, or a quality rating. Data Coverage reflects data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.
Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology